Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:18 May,2020
NIV test can trace Covid-19 antibody just days after infection
PUNE: The blood test based on enzyme-linked immunosorbent assay (or Elisa), recently developed by the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV) in Pune, can pick up the antibody capable of neutralizing SARS-CoV-2 virus in as little as seven to 14 days of Covid-19 infection.
CMAAO IMA Coronavirus Facts and Myth Buster 98: COVID in Children
(With inputs from Dr Monica Vasudev)
The very purpose of life is to face sufferings
According to Hinduism, the fact that we are born means that in our last life, we did not get liberation or Moksha. It also means that some sufferings in our last birth still remained. Therefore, the purpose of this birth is to face those sufferings.
Video of The day
Healthcare News Monitor
Mint- Leroy Leo
Cipla plans to work on multiple drugs to treat coronavirus even as the company works out the finer details of its pact with Gilead Sciences Inc on the experimental antiviral drug remdesivir, the Indian pharmaceutical firm’s chief financial officer Kedar Upadhye told Mint in an interview. “We are trying all avenues. We are attempting to come to the service of patients and try to see that which molecule is more effective. We are trying through all ways. I think we will attack covid-19 through multiple ways," Upadhye said. In generics, there is a combination of zinc, hydroxychloroquine and azithromycin which are being explored in clinical trials, while the lopinavir-ritonavir anti-cancer combination, favipiravir are other generic drugs that are being looked at by Cipla, he said. The Mumbai-based drug maker is already among the four companies with manufacturing plants in India—the other three being Mylan, Jubilant Life Sciences and Hetero Drugs—that have signed a pact with US-based Gilead for manufacturing of the patented drug remdesivir. Gilead had last week signed voluntary licensing agreements with the four companies, as well as Pakistan-based Ferozsons Laboratories, allowing them to manufacture intravenous drug remdesivir for distribution in 127 countries, including India, on a royalty-free basis until a new drug or vaccine is developed against coronavirus. Upadhye said that the five companies are currently chalking out the details of the pact, including decisions on manufacturing facilities, means for transfer of technology and methods to reduce the time taken to produce the drug.
The Indian Express- Sagar Rajput, Tabassum Barnagarwala
It has been more than a month since 10,000 Mumbai Police officers were put on an eight-week dose of Hydroxychloroquine (HCQ), and while they are not being monitored for its impact or otherwise, some officers on the regimen say it is helping them “psychologically”. The drug, which has been pushed by US President Donald Trump as a “game changer” in the fight against Covid-19, is in demand in many parts of the world. But its efficacy is still being clinically tested. Scientists wary of its publicised side effects have warned against mass consumption of HCQ while asking those taking it to do so after consulting doctors. In India, the ICMR has allowed it to be prescribed to all healthcare workers on Covid-19 duty, and asymptomatic household contacts of the infected. In the last week of April, a Maharashtra government notification had prescribed the drug under strict monitoring for health workers and staffers, civic workers as well as people involved in handling quarantine centres, infected patients and containment zones. The Mumbai Police put its personnel on HCQ at the beginning of April when Covid-19 cases started surfacing among personnel deployed on bandobast duty, well before ICMR’s advisory. Police Commissioner Parambir Singh said, “We have provided HCQ dosages to our policemen and if others are willing to take it, then further dosages will be provided to them.” However, the city police does not have a system in place yet to monitor the medicine’s effects on its personnel. Police surgeon Dr S M Patil said he did not know that police personnel have been put on HCQ. “No advice was taken from me,” he said.
Hindustan Times- PTI
The Association of Hospitals of Eastern India (AHEI), a non-statutory body with 17 private medical facilities in Kolkata as members, has written to Chief Secretary Rajiva Sinha seeking his intervention in resolving the crisis. At least 185 nurses left for Manipur earlier this week. On Saturday, 169 followed suit -- 92 hailing from Manipur, 43 from Tripura, 32 from Odisha and two from Jharkhand, sources at the city’s private hospitals said. In his letter, Pradeep Lal Mehta, the president of the AHEI, said, “Although the exact reason why they are leaving is not known, we have found out from other nurses still on duty that the state government of Manipur is offering them a lucrative stipend to return home.” Taking to Facebook, however, Manipur Chief Minister Nongthombam Biren Singh rubbished the claim and said, “No such advisory has been issued by the state. We are not asking anybody to return. We feel proud of them as they serve the patients in Calcutta, Delhi and Chennai.” “We have already said that we will compensate and reward them for treating COVID-19 patients. But if the nurses,doctors don’t feel comfortable in the hospitals where they are working that’s up to them... I cannot force them to stay there. It’s their choice. That might be the reason why they are coming back,” Singh said in a video address. A nurse, who left for Manipur earlier this week, said safety concerns and parental pressure were the two main reasons she quit her job. “Our parents are concerned and we are stressed as the cases here are rising every day. Our state is a green state and we wish to go back. Our state government is helping us. Family and parents are our priority,” one of the nurses said when contacted over phone. A senior official at Bhagirathi Neotia Woman and ChildCare Centre in central Kolkata said many nurses have submitted resignations, while some have refused to report for work.
India Today- Vidya
umbai resident Chaya Kanade, whose mother had a little swelling in her liver went to at least two hospitals until she was finally admitted to the civic-run Sion hospital. Here, the mother tested positive for Covid-19 and has been at the hospital since the last few days. Like other patients, Chaya said, "There are three patients on one bed in the emergency and they make us sit in the emergency for 8 hours. As soon as a patient dies, they do not take away the body immediately. The body remains next to the normal patients for 4-10 hours. The other normal patients feel very scared. The situation is still the same. The dead patient still remains there in black plastic for hours." A video of the hospital had gone viral recently were bodies of dead patients were seen on neighbouring beds where patients were still being treated. According to the hospital authorities, the relatives of the dead patients left and the mortuary was getting full so the dead patients were being kept wrapped up in body bags on the hospital beds for a longer duration. After the video went viral, the embarrassed hospital decided to make amends in its policy to dispose of bodies of the dead Covid-19 patients